AU2003277891A1 - Hcv ns-3 serine protease inhibitors - Google Patents
Hcv ns-3 serine protease inhibitorsInfo
- Publication number
- AU2003277891A1 AU2003277891A1 AU2003277891A AU2003277891A AU2003277891A1 AU 2003277891 A1 AU2003277891 A1 AU 2003277891A1 AU 2003277891 A AU2003277891 A AU 2003277891A AU 2003277891 A AU2003277891 A AU 2003277891A AU 2003277891 A1 AU2003277891 A1 AU 2003277891A1
- Authority
- AU
- Australia
- Prior art keywords
- hcv
- protease inhibitors
- serine protease
- serine
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02021111 | 2002-09-23 | ||
EP02021111.6 | 2002-09-23 | ||
PCT/EP2003/010595 WO2004026896A2 (en) | 2002-09-23 | 2003-09-23 | Hcv ns-3 serine protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003277891A1 true AU2003277891A1 (en) | 2004-04-08 |
Family
ID=32010923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003277891A Abandoned AU2003277891A1 (en) | 2002-09-23 | 2003-09-23 | Hcv ns-3 serine protease inhibitors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003277891A1 (en) |
WO (1) | WO2004026896A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE461209T1 (en) | 2004-01-30 | 2010-04-15 | Medivir Ab | HCV NS-3 SERINE PROTEASE INHIBITORS |
PE20070211A1 (en) | 2005-07-29 | 2007-05-12 | Medivir Ab | MACROCYCLIC COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS |
AR055395A1 (en) | 2005-08-26 | 2007-08-22 | Vertex Pharma | INHIBITING COMPOUNDS OF THE ACTIVITY OF SERINA PROTEASA NS3-NS4A OF HEPATITIS C VIRUS |
US7960506B2 (en) | 2006-12-14 | 2011-06-14 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
CA2677045C (en) | 2007-01-31 | 2016-10-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
CA2682174C (en) | 2007-03-28 | 2021-04-06 | President And Fellows Of Harvard College | Stitched polypeptides |
AU2010204648B2 (en) | 2009-01-14 | 2016-09-01 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
WO2012021876A2 (en) | 2010-08-13 | 2012-02-16 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CN108929375A (en) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | Peptidomimetic macrocyclic compound |
ES2817877T3 (en) | 2012-02-15 | 2021-04-08 | Aileron Therapeutics Inc | Peptidomimetic macrocycles |
WO2013123267A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
JP6526563B2 (en) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | Disubstituted amino acids and methods for their preparation and use |
SG10201902594QA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
BR112017005736A2 (en) | 2014-09-24 | 2017-12-12 | Aileron Therapeutics Inc | peptidomimetic macrocycles and formulations thereof |
CA2979847A1 (en) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
WO2017004548A1 (en) | 2015-07-01 | 2017-01-05 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CN108368161A (en) | 2015-09-10 | 2018-08-03 | 艾瑞朗医疗公司 | Peptidomimetic macrocyclic compound as MCL-1 conditioning agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL129407A0 (en) * | 1996-10-18 | 2000-02-17 | Vertex Pharma | Inhibitors of serine proteases particularly hepatitis C virus NS3 protease pharmaceutical compositions containing the same and the use thereof |
AR029851A1 (en) * | 2000-07-21 | 2003-07-16 | Dendreon Corp | NEW PEPTIDES AS INHIBITORS OF NS3-SERINA PROTEASA DEL VIRUS DE HEPATITIS C |
SV2003000617A (en) * | 2000-08-31 | 2003-01-13 | Lilly Co Eli | INHIBITORS OF PROTEASA PEPTIDOMIMETICA REF. X-14912M |
-
2003
- 2003-09-23 AU AU2003277891A patent/AU2003277891A1/en not_active Abandoned
- 2003-09-23 WO PCT/EP2003/010595 patent/WO2004026896A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004026896A2 (en) | 2004-04-01 |
WO2004026896A3 (en) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI367211B (en) | Hcv ns-3 serine protease inhibitors | |
HK1081196A1 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
HK1090644A1 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
HK1098164A1 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
EP1590442A3 (en) | Macrocyclic hepatitis c serine protease inhibitors | |
HK1095594A1 (en) | 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
PL375486A1 (en) | Potent inhibitor of hcv serine protease | |
AU2002305926A1 (en) | Cysteine protease inhibitors | |
EP1499336A4 (en) | Protease inhibitors | |
AU2003277891A1 (en) | Hcv ns-3 serine protease inhibitors | |
AU2003234630A1 (en) | Cysteine protease inhibitors | |
AU2003256305A1 (en) | Peptidic compounds as cysteine protease inhibitors | |
AU2003269984A1 (en) | Protease inhibitors | |
AU2003247776A1 (en) | Serine protease 16 | |
AU2002342682A1 (en) | Protease inhibitors | |
AU2003263738A1 (en) | Protease inhibitors | |
AU2003292406A1 (en) | Serine protease | |
AU2003252734A1 (en) | Novel serine protease | |
AU2002325108A1 (en) | Serine protease inhibitor and processes for the preparation thereof | |
AU2002363791A1 (en) | Protease enzyme inhibitors | |
AU2003287325A1 (en) | N-cycloalkylglycines as hiv protease inhibitors | |
AU2003233642A1 (en) | Protease inhibitors | |
AU2003304496A1 (en) | Protease inhibitors | |
AU2003252417A1 (en) | Protease inhibitor | |
AU2003265240A1 (en) | Protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |